Project Grant R35GM152121

Award Date 8/1/24
Completion Date 7/31/29
Dollars Obligated $744K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30318, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $1,188,750 in funding to Vanderbilt University to conduct research on fatty acid oxygenases and their lipid mediator products. The research program focuses on technically challenging questions related to lipoxygenases, their associated enzymes and proteins, and the mechanisms of biosynthesis and fate of oxidation products....
This Project Grant award, ID R35GM158174, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award totaling $394,214 supports research at Oregon Health & Science University (OHSU) to investigate the intracellular transfer of lipids between cellular membranes. The key objectives of this 5-year project are to: 1) characterize the lipid transport functions of the proteins MPP6 and ATP11A, 2)...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $609,493 to the Sloan-Kettering Institute for Cancer Research to conduct research on the molecular mechanisms underlying lipid and energy storage in cells. The award will fund studies to elucidate the structure, function, and cell biological roles of key enzymes and protein complexes involved in triacylglycerol synthesis and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) is focused on unraveling the molecular interconnections between circadian rhythms and lipid metabolism. The $574,021 award, effective from February 1, 2025 to January 31, 2030, aims to address three key knowledge gaps: 1) how phosphatidic acid (PA) mediates nuclear processes, 2) how PA and lipid metabolism modulate the molecular clock,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $172,300.00 to the University of California, Los Angeles (UCLA) to investigate the role of peroxisomal PEX family proteins, specifically PEX6 and PEX14, in regulating hepatic bile acid and lipid metabolism. The research aims to determine how disrupting these PEX proteins affects the...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $1.33M Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Northeastern University in Boston, MA. The grant supports research to develop mechanistic, predictive models for understanding how lipids in drug delivery systems and food impact the absorption of orally delivered compounds, including drugs, nutrients, and toxins. The key goals are to: 1) determine if systems-based modeling can describe...
The National Institute of General Medical Sciences (NIGMS) awarded a $397,771 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Research Foundation For The State University Of New York (RF SUNY) to study the role of lipids in regulating necroptosis, a form of regulated cell death. The project aims to identify lipid modulators of necroptosis, investigate mechanisms that activate lipid production during necroptosis, and characterize how lipid...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $350,000 to Sinopia Biosciences Inc. to develop computational methods for predicting the metabolomic profiles of unscreened chemical compounds. The goal is to enable more efficient metabolomics-based drug discovery by combining sparse experimental screening with computational inference. Key objectives include: 1) developing methods to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $1,343,944 to Vanderbilt University to conduct research on the functional roles of human cytochrome P450 enzymes. The key objectives of the research include: Investigating whether the compound I intermediate (FeO3+) is the only oxidant involved in P450 reactions, including steroid C-C bond cleavages. Determining...
The National Institute of General Medical Sciences (NIGMS) awarded a $647,301 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Massachusetts Institute of Technology (MIT) to advance the understanding of iron-sulfur enzyme mechanisms. The 5-year project aims to develop synthetic models of iron-sulfur clusters and new spectroscopic methods to better characterize the structure and reactivity of iron-sulfur enzymes, which are critical for human health...

BIOCHEMISTRY OF MEMBRANE PROTEINS INVOLVED IN LIPID AND CANNABINOID METABOLISM - PROJECT SUMMARY THE LONG-TERM GOALS OF THE DAS LAB ARE TO IDENTIFY THE FUNDAMENTAL BIOCHEMICAL MECHANISMS UNDERLYING LIPID METABOLISM AND LIPID-LIKE XENOBIOTICS SUCH AS CANNABINOIDS. IN THE BACKDROP OF GROWING RECOGNITION OF LIPIDS IN THE BODY AND SPARSE KNOWLEDGE OF THEIR BIOCHEMISTRY AND FUNCTION, THE DAS LAB RESEARCH PROGRAM ADDRESSES THE FOLLOWING TWO BROAD GOALS: (1) TO UNDERSTAND THE MECHANISM OF HOW MEMBRANE PROTEINS METABOLIZE LIPIDS AND LIPID-LIKE XENOBIOTICS, AND (2) TO IDENTIFY NOVEL LIPID METABOLITES THAT ARE FORMED FROM THE METABOLISM AND ELUCIDATE THEIR PHARMACOLOGY WITH RESPECT TO RECEPTOR INTERACTIONS THAT ARE INVOLVED IN IMMUNOMODULATION. TO EXECUTE THESE RESEARCH GOALS, DAS LAB USES DIVERSE SET OF INNOVATIVE METHODOLOGIES SPANNING FROM CHEMICAL SYNTHESIS, RECOMBINANT MEMBRANE PROTEIN EXPRESSION, NANODISCS, TARGETED AND UNTARGETED LIPIDOMICS MASS SPECTROMETRY, UV-VIS AND FLUORESCENCE SPECTROSCOPY, MOLECULAR DYNAMICS, IMAGING PLATFORMS, MAMMALIAN CELL CULTURE AND RECEPTOR PHARMACOLOGICAL STUDIES. THE PROJECT FALLS UNDER THE BROADER NIGMS MISSION AS THE ELUCIDATION OF THE BASIC MECHANISMS OF MEMBRANE PROTEIN INTERACTIONS WITH LIPIDS AND LIPID-LIKE XENOBIOTICS WILL LAY THE FOUNDATION FOR THE DEVELOPMENT OF THERAPEUTICS FOR DIFFERENT DISEASES. THE LABORATORY ESTABLISHED IN 2012 HAS BEEN NIGMS FUNDED AND HAVE PUBLISHED 52 PAPERS FROM THE INDEPENDENT LABORATORY FOCUSING ON CYP MEDIATED METABOLISM OF LIPIDS. THE WORK WAS RECOGNIZED BY FOUR NATIONAL AWARDS AND NUMEROUS OPPORTUNITIES TO DELIVER TALKS AT CONFERENCES AND OTHER ACADEMIC INSTITUTIONS. PREVIOUSLY, THE DAS LAB HAVE COMBINED USE OF CROSS-DISCIPLINARY APPROACHES TO UNDERSTAND THE ROLE OF THE LIPID ENDOCANNABINOID METABOLISM BY MEMBRANE-BOUND ENZYMES TO SYNTHESIZE NOVEL METABOLITES THAT EFFECT NEUROINFLAMMATION. OVERALL, THE LAUDABLE QUALITY OF OUR RESEARCH PROGRAM HAS BEEN IDENTIFICATION OF IMPORTANT SCIENTIFIC PROBLEMS, PROPOSAL OF DIVERSE SOLUTIONS AND FINDING COLLABORATORS TO TRANSLATE AND STRENGTHEN THE RESEARCH QUESTION AND APPROACH. USING THE TOOLS AND APPROACHES DEVELOPED IN PREVIOUS NIGMS FUNDING, WE WILL LEVERAGE SUPPORT FROM THE MIRA TO UNDERSTAND THE BIOCHEMISTRY OF NEW ORPHAN CYTOCHROME P450S EXPRESSED DURING DISEASES STATES AND INVOLVED IN LIPID METABOLISM. THE STRENGTH IN OUR STUDIES LIES IN THE CENTRAL HYPOTHESIS THAT P450 MEDIATED METABOLISM OF BOTH LIPIDS AND CANNABINOIDS LEADS TO THE FORMATION OF BIOACTIVE MOLECULES THAT ARE PROMISING SCAFFOLD TO DEVELOP THERAPEUTICS TO TREAT IMMUNE DISEASES. ALTOGETHER, THE PROPOSAL RESEARCH WILL COMPREHENSIVELY ADDRESS THE MECHANISM OF LIPID MEMBRANE PROTEIN INTERACTIONS LEADING TO THE FORMATION OF LARGE REPERTOIRE OF LIPID METABOLITES THAT ARE INVOLVED IN CONTROLLING SYSTEMIC INFLAMMATION.

Posted 8/1/24, 12:00 AM